Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.

Clinical trial NCT06447506 · TERMINATED

Trial details

NCT number: NCT06447506
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2024-06-05
Primary completion: 2025-07-29
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.